KLP Kapitalforvaltning’s Arcus Biosciences RCUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$499K Hold
19,300
– – ﹤0.01% 1478
2026
Q2
$595K Hold
19,300
– – ﹤0.01% 1435
2026
Q1
$417K Buy
19,300
+1,100
+6% +$23.8K ﹤0.01% 1501
2025
Q4
$434K Sell
18,200
-3,700
-17% -$75.5K ﹤0.01% 1482
2025
Q3
$298K Hold
21,900
– – ﹤0.01% 1657
2025
Q2
$178K Buy
21,900
+8,000
+58% +$68.3K ﹤0.01% 1831
2025
Q1
$109K Hold
13,900
– – ﹤0.01% 1993
2024
Q4
$207K Buy
+13,900
New +$227K ﹤0.01% 1807

Other funds holding RCUS

KLP Kapitalforvaltning's RCUS Position: Q3 2026 in Review

KLP Kapitalforvaltning held its Arcus Biosciences (RCUS) position steady in Q3 2026 at 19,300 shares worth $499K. The position accounts for ﹤0.01% of the portfolio, ranked #1478.

KLP Kapitalforvaltning first reported a position in RCUS in Q4 2024 and has held it in 8 quarters since. The position peaked at $595K in Q2 2026. 218 funds tracked by Wall St. Rank hold RCUS as of Q3 2026.

  • KLP Kapitalforvaltning held 19,300 shares of Arcus Biosciences worth $499K as of Q3 2026.
  • KLP Kapitalforvaltning left its Arcus Biosciences share count unchanged in Q3 2026.
  • Arcus Biosciences made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q3 2026, its #1478 holding.
  • KLP Kapitalforvaltning first reported a position in Arcus Biosciences in Q4 2024 and has held it in 8 quarters since.
  • KLP Kapitalforvaltning's Arcus Biosciences position peaked at $595K in Q2 2026.
  • 218 funds tracked by Wall St. Rank held Arcus Biosciences as of Q3 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q3 2026, filed 10 Nov 2026.